To validate the expression of NT5E and PD-L1 proteins in breast cancer, immunohistochemical (IHC) staining was conducted on 39 breast cancer tissues from our clinical specimen bank to analyze the correlation between NT5E and PD-L1 (Fig. 2A,B). The gene discussed is CD274; the disease is breast carcinoma.